TRAIL and interferon-alpha act synergistically to induce renal cell carcinoma ... - UroToday Print
UroTodayDespite modern targeted therapy metastatic renal cell carcinoma remains a deadly disease. Interferon-alpha (Calbiochem(R)) is currently used to treat this

... read more